Cemented Acetabular Cups Clinical Study
- Conditions
- Total Hip Arthroplasty
- Interventions
- Device: Mueller cemented cups
- Registration Number
- NCT04831918
- Lead Sponsor
- Limacorporate S.p.a
- Brief Summary
This clinical study has the aim to evaluate clinical, radiographic, patient-reported outcomes of total hip arthroplasty with the implant of Mueller cemented acetabular cups up to 2 years after surgery, in order to assess the performance of the device. Furthermore, it aims to collect short-term survivorship of the implant and the incidence of early complications.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 45
-
The patient has participated in the Informed Consent process and has signed the Informed Consent form previously approved by the Ethics Committee;
-
The patient diagnosis is one or more of the following:
- Patient with advanced articular destruction generated by primary degenerative or post-traumatic arthrosis or rheumatoid arthritis;
- Patient with avascular necrosis of the femoral head or fracture of the femoral neck;
- Patient with congenital or acquired deformity;
- Patient with failures of previous operations, like osteosynthesis, articular reconstruction, arthrodesis, hemi-arthroplasty or total arthroplasty.
-
The patient is willing and able to complete scheduled follow-up evaluations as described in the Patient Information Sheet;
The patient should be excluded from the study if he/she meets any of the following criteria, which reflect the cemented acetabular cup contraindication for use:
- Acute or chronic infections, local or systemic infections;
- Serious muscular, neurological or vascular diseases affecting the concerned limb;
- Any concomitant disease and dependence that might affect the implanted prosthesis;
- Allergy to material;
- Metal-on-metal systems: patients with renal impairment.
- Patient's age<18
- Female patients who are pregnant, nursing, or planning a pregnancy.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Mueller cemented cups Mueller cemented cups Patients undergo total hip arthroplasty with the implant of the Mueller cemented cup as acetabular component.
- Primary Outcome Measures
Name Time Method Clinical progression of Harris Hip Score (HHS) from baseline to 2 years after surgery 2 years Follow up HHS ranges from 0 to 100, being 0 the worst and 100 the best conditions. HHS is reported as 90-100 for excellent results, 80-90 for good, 70-79 for fair, 60-69 for poor, and below 60 for a failed result. The outcome is considered satisfactory for values over 80
- Secondary Outcome Measures
Name Time Method Implant survivorship (Kaplan-Meier estimate) at 2 years after surgery 2 years FU Clinical progression of HOOS up to 2 years FU, compared to the baseline 6 weeks, 1 year and 2 years FU Hip disability and osteoarthritis outcome score (HOOS) is a patient-reported outcome measurement, that ranges from 0 to 100, with 100 indicating no symptoms and 0 indicating extreme symptoms
Change in TUG from preoperative up to 2 years FU 6 weeks, 1 year and 2 years FU Timed Up and Go
Clinical progression of HHS up to 1 year FU, compared to the baseline 6 weeks, 1 year Harris Hip Score
Radiographic evaluation and stability assessment of the implant up to 2 years FU 6 weeks, 1 year and 2 years FU Radiographic stability, radiographically detectable complications
Incidence of device-related AE/SAE up to 2 years of follow-up 6 weeks, 1 year and 2 years FU Adverse events and device deficiencies
Trial Locations
- Locations (1)
Ospedale San Camillo di Trento
🇮🇹Trento, TN, Italy